Anti-VEGF Receptor 1 antibody [Y103]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
5
(21 Reviews)
|
(400 Publications)
Anti-VEGF Receptor 1 antibody [Y103] (ab32152) is a rabbit monoclonal antibody detecting VEGF Receptor 1 in Western Blot, IP, IHC-P. Suitable for Chinese hamster, Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 300 publications
- Trusted since 2006
View Alternative Names
FLT, FRT, VEGFR1, FLT1, Vascular endothelial growth factor receptor 1, VEGFR-1, Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular permeability factor receptor, FLT-1
- IP
Lab
Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
VEGF Receptor 1 was immunoprecipitated from 0.35 mg mouse brain lysate 10μg with ab32152 at 1 : 30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab32152 1 : 1000 dilution (2 μg/ml). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1 : 1000 dilution.
Lane 1 : Mouse brain lysate 10μg.
Lane 2 : ab32152 IP in mouse brain lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab32152 in mouse brain lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] (ab32152)
Predicted band size: 151 kDa
false
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Immunohistochemical analysis of formalin fixed paraffin embedded human placenta labelling VEGF Receptor 1 with ab32152 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab32152 anti-VEGF Receptor 1 antibody [Y103] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Immunohistochemical analysis of paraffin-embedded Human gastric carcinoma tissue labeling VEGF with ab32152, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on human gastric carcinoma. Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Immunohistochemical analysis of formalin fixed paraffin embedded human stomach adenocarcinoma labelling VEGF Receptor 1 with ab32152 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab32152 anti-VEGF Receptor 1 antibody [Y103] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
AbReview77520****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Immunohistochemistry analysis (Formalin/PFA-fixed paraffin-embedded sections) of paraformaldehyde fixed, 1% TritonX-100 in PBS permeabilized human Metastatic melanoma tissue. Stained with ab32152 at 1/100 dilution. Secondary antibody used was HRP Donkey Jackson Immuno Anti-rabbit at 1/500 dilution. Blocking was done with 3% donkey serum for 30 minutes at 25°C. The sample was incubated with the primary antibody and 1% donkey serum for 1 hour at 25°C. Antigen retrieval method was heat mediated Tris-EDTA
This image is courtesy of an anonymous Abreview
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human abdominal aortic aneurysm (AAA) wall tissue sections labeling VEGF Receptor 1 with ab32152 at 1/100 dilution.
Resected aortic tissues were immersed in 10% neutral buffered formalin for at least 24 h for immunohistochemical staining. Tissue sample was embedded in paraffin; 4 μm sections were cut and mounted onto MAS-coated slides. The sections were deparaffinized, dehydrated, and boiled in a pressure cooker in 0.01 M citric acid buffer (pH 6.0) for 20 min. The sections were washed with phosphate-buffered saline and incubated with 3% H2O2 in absolute methanol for 5 min to inhibit any endogenous peroxidase activity. Sections were preincubated with 3% normal goat serum for 20 min to minimize nonspecific binding to VEGF Receptor 1, and incubated with ab32152 at 4°C overnight in a moist chamber. The section was washed with phosphate-buffered saline and then incubated with the appropriate secondary antibody for 30 min at room temperature. Staining was visualized with Vector DAB, and tissue section was then counterstained with hematoxylin.
Image from Sano M et al. PLoS ONE. 2014 Mar 20; 9(3). Fig 2E. DOI 10.1371/journal.pone.0089830. Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm. e89830.
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. Lysates were not boiled.
Lanes 1 - 2:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/1000 dilution
Lanes 1 - 2:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/vegf-receptor-1-antibody-y103-bsa-and-azide-free-ab210608'>ab210608</a>)
Lanes 1 - 2:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (<a href='/en-us/products/primary-antibodies/vegf-receptor-1-antibody-y103-low-endotoxin-azide-free-ab184784'>ab184784</a>)
Lanes 1 - 2:
Western blot - Anti-6X His tag® antibody [EPR20547] - ChIP Grade (<a href='/en-us/products/primary-antibodies/6x-his-tag-antibody-epr20547-chip-grade-ab213204'>ab213204</a>) at 1/5000 dilution
Lane 1:
HEK-293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a His tag whole cell lysate at 20 µg
Lane 2:
HEK-293T (human embryonic kidney epithelial cell) cells transfected with sFlt1 (P17948-2) expression vector containing a His -tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 77 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/1000 dilution
Lane 1:
Mouse brain lysates at 15 µg
Lane 2:
Human brain lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 151 kDa
Observed band size: 180 kDa
false
Exposure time: 40s
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000,000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) 1 : 5,000 dilution used as loading control.
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/1000 dilution
Lane 1:
HEK-293T (human embryonic kidney epithelial cell) cells transfected with an empty vector contain a His-tag whole cell lysate at 20 µg
Lane 2:
HEK-293T cells transfected with a human VEGF Receptor 1 expression vector containing a His-tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 180 kDa
false
Exposure time: 1s
- WB
Unknown
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/10000 dilution
All lanes:
mouse brain tissue
Predicted band size: 151 kDa
Observed band size: 180 kDa
false
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (AB32152)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000,000 dilution.
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/1000 dilution
Lane 1:
Mouse placenta tissue lysate at 20 µg
Lane 2:
Rat placenta tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 180 kDa
false
Exposure time: 10s
Related conjugates and formulations (8)
-
Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free
-
Anti-VEGF Receptor 1 antibody [Y103] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-VEGF Receptor 1 antibody [Y103]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-VEGF Receptor 1 antibody [Y103]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-VEGF Receptor 1 antibody [Y103]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-VEGF Receptor 1 antibody [Y103]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-VEGF Receptor 1 antibody [Y103]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-VEGF Receptor 1 antibody [Y103]
Reactivity data
Product details
Product Specifications
Anti-VEGF Receptor 1 antibody [Y103] (ab32152) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, IP, WB in hamster, human, mouse, rat samples.
Anti-VEGF Receptor 1 antibody [Y103] (ab32152) specifically detects VEGF Receptor 1 (UniProt ID: P17948; Molecular weight: 148kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-VEGF Receptor 1 antibody [Y103] (ab32152) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-VEGF Receptor 1 antibody [Y103] (ab32152) has been cited over 308 times in peer reviewed journals and is trusted by the scientific community.
Anti-VEGF Receptor 1 antibody [Y103] (ab32152) has 21 independent reviews from customers.
Related Products
Antibody clone Y103 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 555, Alexa Fluor® 647, Alexa Fluor® 594, Alexa Fluor® 568, Alexa Fluor® 750 (ab309078, ab309079, ab309080, ab311783, ab313064, ab321585).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FLT-1 mediates important cellular responses such as cell migration and proliferation. Although it often functions in conjunction with other receptors like VEGFR-2 FLT-1 has unique binding affinities that modulate the availability of VEGF for other receptors. FLT-1 proteins as part of complex signaling networks actively contribute to maintaining vascular homeostasis and regulating blood vessel permeability.
Pathways
FLT-1 is an important component in the VEGF signaling pathway and also part of the PlGF/VEGF pathway. The receptor serves as a decoy to regulate the amount of VEGF interaction with VEGFR-2 influencing endothelial cell function and vascular permeability. By sequestering VEGF FLT-1 helps maintain the balance in this angiogenic signaling network interacting with proteins like VEGF PlGF and the anti-VEGF agents that target these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (400)
Recent publications for all applications. Explore the full list and refine your search
TH open : companion journal to thrombosis and haemostasis 9:a27014242 PubMed41059381
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1650614 PubMed40977893
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 45:806-816 PubMed40810226
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1521 PubMed40788438
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1644436 PubMed40766765
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current issues in molecular biology 47: PubMed40728968
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed40710304
2025
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 20:e0325936 PubMed40601668
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of ophthalmology 18:792-801 PubMed40385128
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical epigenetics 17:82 PubMed40380281
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com